Huaye Fragrances: Report for the third quarter of 2024

SZSIOct 25 00:00 · Announcements

Anhui Hyea Aromas (300886.SZ) currently has not directly cooperated with COFCO or China Resources.

Guangzhou Huaye Aroma (300886.SZ) stated on the investor interaction platform on September 11 that the company's main products are gamma-decalactone and delta-decalactone series aromas, which are generally not directly applied to consumer products, but sold to flavor companies (such as Huabond, Firmenich, Symrise, and International Flavors & Fragrances) and then formulated into flavors for use in products such as csi sws food & beverage index, cosmetics (perfume, cosmetics, bath products, detergents, and cleaners), fodder and other industries. The company's products are mainly supplied to international flavor and fragrance enterprises, and currently have not directly cooperated with COFCO and CR Vanguard.

Gelonghui FinanceSep 11 17:09

Anhui Hyea Aromas: Half-year report for the year 2024.

SZSIAug 22 00:00 · Announcements

Anhui Hyea Aromas: Summary of Half-Year Report in 2024.

SZSIAug 22 00:00 · Announcements

Anhui Hyea Aromas (300886.SZ): net income in the first half of the year was 13.7448 million yuan, a year-on-year increase of 698.97%.

On August 21, Anhui Hyea Aromas (300886.SZ) released its semi-annual report for 2024, with operating revenue of 0.173 billion yuan, a year-on-year increase of 29.75%; net income attributable to shareholders of the listed company was 13.7448 million yuan, a year-on-year increase of 698.97%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 11.94496 million yuan, a year-on-year increase of 1,348.70%; basic earnings per share was 0.1844 yuan.

Gelonghui FinanceAug 21 18:46

Huaye Fragrance (300886.SZ): Currently not involving the application of synthetic biological technology

Gelonghui, May 8 | Huaye Fragrances (300886.SZ) said on the investor interactive platform that our main products are lactone series synthetic fragrances, which currently do not involve the application of synthetic biological technology.

Gelonghui FinanceMay 8 16:47